Terrexine LC Intramammary Suspension for lactating cows
Terrexine LC Intramammary Suspension for lactating cows
Authorised
- Cefalexin monohydrate
- KANAMYCIN MONOSULPHATE
Product identification
Medicine name:
Terrexine LC Intramammary Suspension for lactating cows
Active substance:
- Cefalexin monohydrate
- KANAMYCIN MONOSULPHATE
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefalexin monohydrate210.36milligram(s)1.00Syringe
-
KANAMYCIN MONOSULPHATE100000.00international unit(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal7day
-
Milk108hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- A white 10 g LPDE intramammary syringe (12 ml) comprising of barrel, plunger and a blue sealed sterile tip (cap). 20 tubes percarton.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Univet Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Univet Limited
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10990/023/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
How useful was this page?: